Annual Working Capital
$193.38 M
-$42.79 M-18.12%
31 December 2023
Summary:
PMV Pharmaceuticals annual working capital is currently $193.38 million, with the most recent change of -$42.79 million (-18.12%) on 31 December 2023. During the last 3 years, it has fallen by -$164.97 million (-46.04%). PMVP annual working capital is now -46.04% below its all-time high of $358.35 million, reached on 31 December 2020.PMVP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$176.06 M
-$31.35 M-15.11%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly working capital is currently $176.06 million, with the most recent change of -$31.35 million (-15.11%) on 30 September 2024. Over the past year, it has dropped by -$18.52 million (-9.52%). PMVP quarterly working capital is now -52.18% below its all-time high of $368.20 million, reached on 30 September 2020.PMVP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.1% | -9.5% |
| 3 y3 years | -46.0% | -42.3% |
| 5 y5 years | +222.8% | - |
PMVP Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -46.0% | at low | -42.3% | at low |
| 5 y | 5 years | -46.0% | +222.8% | -52.2% | +80.4% |
| alltime | all time | -46.0% | +222.8% | -52.2% | +80.4% |
PMV Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $176.06 M(-15.1%) |
| June 2024 | - | $207.40 M(+8.9%) |
| Mar 2024 | - | $190.40 M(-1.5%) |
| Dec 2023 | $193.38 M(-18.1%) | $193.38 M(-0.6%) |
| Sept 2023 | - | $194.58 M(+8.7%) |
| June 2023 | - | $178.97 M(-19.6%) |
| Mar 2023 | - | $222.69 M(-5.7%) |
| Dec 2022 | $236.17 M | $236.17 M(-6.8%) |
| Sept 2022 | - | $253.52 M(-6.3%) |
| June 2022 | - | $270.48 M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $276.36 M(-4.4%) |
| Dec 2021 | $289.07 M(-19.3%) | $289.07 M(-5.2%) |
| Sept 2021 | - | $304.99 M(-3.4%) |
| June 2021 | - | $315.58 M(-4.1%) |
| Mar 2021 | - | $329.16 M(-8.1%) |
| Dec 2020 | $358.35 M(+267.3%) | $358.35 M(-2.7%) |
| Sept 2020 | - | $368.20 M(+142.7%) |
| June 2020 | - | $151.70 M(+55.5%) |
| Dec 2019 | $97.57 M(+62.9%) | $97.57 M |
| Dec 2018 | $59.91 M | - |
FAQ
- What is PMV Pharmaceuticals annual working capital?
- What is the all time high annual working capital for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual working capital year-on-year change?
- What is PMV Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly working capital year-on-year change?
What is PMV Pharmaceuticals annual working capital?
The current annual working capital of PMVP is $193.38 M
What is the all time high annual working capital for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual working capital is $358.35 M
What is PMV Pharmaceuticals annual working capital year-on-year change?
Over the past year, PMVP annual working capital has changed by -$42.79 M (-18.12%)
What is PMV Pharmaceuticals quarterly working capital?
The current quarterly working capital of PMVP is $176.06 M
What is the all time high quarterly working capital for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly working capital is $368.20 M
What is PMV Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, PMVP quarterly working capital has changed by -$18.52 M (-9.52%)